Invasive lobular, low-grade and HER-2-negative breast cancers are more detectable with digital breast tomosynthesis (DBT) than full-field digital mammography (FFDM) when imaging patients with dense breasts, according to a new study published in the Korean Journal of Radiology.

CVS Health and Walmart have reached a new, multiyear deal to continue their pharmacy business relationship. CVS announced the agreement Jan. 18, three days after the companies stated they would no longer be in the same network for filling prescription drugs after a pricing dispute.

Following a series of valsartan recalls over carcinogenic impurities, at least three sellers of the popular blood-pressure medication hiked their prices, the Wall Street Journal reported.

It was a record-breaking year for global venture capital (VC) funding in digital health, with more than $9.5 billion raised in 698 deals for 2018, according to a report by Mercom Capital Group. The previous record was set last year, with $7.2 billion raised in 778 deals.

Over the past two decades, the workload of radiology trainees has focused more and more on noninvasive diagnostic imaging services, according to new research published in the Journal of the American College of Radiology.

The FDA recently gave 501(k) clearance to medical imaging device iCertainty which noninvasively shows blood flow without the need of injection, dyes or radiation.

CMS’ Center for Medicare and Medicaid Innovation (CMMI) has announced a new model that aims to lower prescription drug prices in Medicare Part D and introduced several updates to Medicare Advantage (MA) plans.

The Trump administration’s CMS has proposed a number of changes to the 2020 coverage year, including making changes to the individual health insurance exchange and qualified health plan provisions.